Last updated: April 5, 2026
What is the excipient composition and strategy for GOOD NEIGHBOR PHARMACY IBUPROFEN PM?
The product combines the active pharmaceutical ingredient (API), ibuprofen, with excipients tailored to enhance stability, absorption, and patient compliance. The typical formulation includes:
- Ibuprofen: 200 mg per tablet (standard OTC strength).
- Diluents: Microcrystalline cellulose, to provide bulk and aid in tablet formation.
- Binders: Hydroxypropyl methylcellulose (HPMC), for ensuring tablet cohesion.
- Disintegrants: Crosscarmellose sodium, facilitating rapid breakdown upon ingestion.
- Lubricants: Magnesium stearate, to ease manufacturing and prevent sticking.
- Flavoring agents: Limited, given the PM formulation targets nighttime relief, focusing instead on coating or secondary dosing considerations.
The product’s excipient strategy leverages excipients compatible with over-the-counter (OTC) formulations, emphasizing stability, palatability, and rapid disintegration. The inclusion of non-hypersensitive disintegrants and appropriate binders is critical for ensuring consistent release and faster onset of action.
How does excipient selection impact the product's marketability?
Excipients influence both safety and consumer perception. For IBUPROFEN PM, the focus is on minimizing gastrointestinal irritation and ensuring night-time tolerability. As such, formulation strategies include:
- Gelling agents or coatings: To reduce gastric mucosa irritation.
- Sweeteners or flavor modifiers: To improve taste, especially for children or sensitive populations.
- Extended-release options: For sustained relief during sleep, though the standard formulation is immediate-release.
The excipient strategy aims to optimize these attributes, giving the product competitive differentiation.
What are the commercial opportunities related to excipient innovation?
Potential market opportunities include:
- Formulation innovations: Developing low-GI irritant, gastro-resistant, or coated formulations. For example, controlled-release versions could extend dosing intervals.
- Novel excipients: Incorporating non-traditional excipients such as plant-based polymers or biodegradable carriers to boost appeal in natural or eco-conscious market segments.
- Flavor and compliance enhancements: Creating more palatable formulations for pediatric or sensitive adults, potentially commanding premium pricing.
- Combination products: Using excipients to deliver ibuprofen alongside other sleep aids or analgesics, creating multi-action OTC products.
Market analysis indicates OTC ibuprofen products generate billions annually, with PM formulations seeing increased demand among consumers seeking nighttime pain relief without gastrointestinal side effects.[1]
How does excipient regulation influence product development?
Regulatory pathways for excipients differ globally. In the U.S., the FDA mandates Generally Recognized as Safe (GRAS) status for excipients. The European Medicines Agency (EMA) requires detailed safety assessments for new excipients or novel uses.
Compliance impacts formulation choices, especially for OTC products. The strategy involves selecting excipients with established safety profiles, minimizing regulatory delays and enabling faster time-to-market.
How does supply chain affect excipient strategy?
Availability, quality, and cost of excipients influence formulation decisions. Supply chain disruptions can enable or constrain innovation. For instance:
- US-based manufacturers prioritize excipients with reliable sourcing.
- Adoption of alternative green excipients depends on their availability at scale.
- Cost advantages drive decisions to use established excipients versus novel alternatives.
What is the outlook for patent and regulatory exclusivity?
Excipients are typically "wear-out" elements, with limited patent protection. However, formulations with unique combinations or delivery mechanisms can secure utility patents. Regulatory exclusivities for the overall product last 5 years in the U.S. and 10 years in the EU, but novel excipient combinations may extend lifecycle opportunities.
Companies investing in excipient innovation can leverage exclusivities through novel formulations, extended use patents, or novel delivery systems designed with excipient modifications.
Key market data and trends
| Parameter |
Details |
| Global ibuprofen market |
Estimated at USD 4.8 billion in 2021 [2] |
| OTC analgesic segment |
Accounts for approximately 70% of total ibuprofen sales |
| Night-time OTC product share |
Growing at 4% CAGR from 2021-2026 [3] |
| Patent landscape |
Limited patent protection for excipients; focus on formulation innovations |
Key competitive differentiators
- Gastro-resistant coatings tailored for nighttime use.
- Palatable formulations targeting children or sensitive adults.
- Extended-release formulations leveraging novel excipients.
- Eco-friendly excipients to appeal to environmental-conscious consumers.
Conclusion
The excipient composition and formulation strategies for GOOD NEIGHBOR PHARMACY IBUPROFEN PM focus on safety, efficacy, and consumer preferences. Innovation in excipients and formulation can unlock new market segments and extend product lifecycle. Market opportunities exist in developing controlled-release, gastro-resistant, or natural excipient-based formulations to meet evolving consumer demands.
Key Takeaways
- Excipient strategies emphasize safety, stability, and rapid disintegration.
- Formulation innovations can lead to competitive advantages and patent protections.
- Regulatory considerations heavily influence excipient selection.
- Market growth in OTC analgesics, notably nighttime pain relief, supports expansion.
- Supply chain stability is critical in excipient sourcing decisions.
FAQs
Q1: Can novel excipients be used in OTC ibuprofen PM formulations?
Yes. However, they require extensive safety data and regulatory approval. The process may extend development timelines.
Q2: How does excipient choice influence gastrointestinal tolerability?
They determine irritation potential; coatings or gastro-resistant excipients can reduce gastrointestinal side effects and improve nighttime tolerability.
Q3: What opportunities exist for combination products involving ibuprofen PM?
Combining analgesic and sleep-aid properties using excipients can create multi-action OTC products, targeting consumers seeking effective night-time relief.
Q4: Are there regulatory incentives for innovating excipient strategies?
Regulatory pathways focus on safety profiles, but new formulations incorporating novel excipients may qualify for patent protections and certain exclusivities.
Q5: How does consumer demand impact excipient selection?
Preference for natural, non-allergenic, and eco-friendly excipients influences formulation choices and marketing strategies.
References
[1] Statista. (2022). Over-the-counter (OTC) analgesics global revenue.
[2] MarketsandMarkets. (2021). Ibuprofen market size.
[3] Transparency Market Research. (2022). OTC sleep aid market analysis.
